Cutera (NASDAQ:CUTR) Stock Rating Lowered by William Blair

Cutera (NASDAQ:CUTR – Get Rating) was downgraded by equities research analysts at William Blair from an “outperform” rating to a “market perform” rating in a research note issued to investors on Thursday, The Fly reports.

A number of other analysts have also recently issued reports on CUTR. Stephens reiterated an “overweight” rating and set a $46.00 target price on shares of Cutera in a report on Friday, April 14th. Cantor Fitzgerald decreased their price target on shares of Cutera from $33.00 to $21.00 in a research report on Wednesday. Piper Sandler began coverage on shares of Cutera in a research report on Wednesday. They set an “underweight” rating and a $14.00 price target for the company. StockNews.com began coverage on Cutera in a report on Thursday, March 16th. They issued a “sell” rating for the company. Finally, Maxim Group cut Cutera from a “buy” rating to a “hold” rating in a report on Thursday, March 30th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company. According to MarketBeat, Cutera has an average rating of “Hold” and an average target price of $32.75.

Cutera Stock Up 2.6 %

Shares of NASDAQ CUTR opened at $14.51 on Thursday. The firm’s 50 day moving average price is $24.34 and its 200 day moving average price is $34.66. The company has a debt-to-equity ratio of 19.38, a quick ratio of 3.66 and a current ratio of 4.26. The firm has a market cap of $287.15 million, a P/E ratio of -3.31 and a beta of 1.56. Cutera has a 1 year low of $13.21 and a 1 year high of $54.91.

Cutera (NASDAQ:CUTR – Get Rating) last posted its quarterly earnings results on Tuesday, May 9th. The medical device company reported ($1.26) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.96). Cutera had a negative net margin of 32.62% and a negative return on equity of 489.05%. The business had revenue of $55.00 million during the quarter, compared to analysts’ expectations of $59.80 million. During the same quarter last year, the firm earned ($0.84) EPS. The firm’s quarterly revenue was down 5.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that Cutera will post -1.37 earnings per share for the current year.

Hedge Funds Weigh In On Cutera

Several large investors have recently modified their holdings of the stock. Point72 Asset Management L.P. lifted its stake in Cutera by 88.7% during the fourth quarter. Point72 Asset Management L.P. now owns 537,100 shares of the medical device company’s stock worth $23,751,000 after purchasing an additional 252,400 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in Cutera by 652.9% in the second quarter. Wells Fargo & Company MN now owns 253,054 shares of the medical device company’s stock worth $9,489,000 after acquiring an additional 219,442 shares during the last quarter. Eagle Asset Management Inc. lifted its holdings in Cutera by 42.7% in the third quarter. Eagle Asset Management Inc. now owns 628,414 shares of the medical device company’s stock worth $28,655,000 after acquiring an additional 188,103 shares during the last quarter. Paradigm Capital Management Inc. NY lifted its holdings in Cutera by 38.4% in the first quarter. Paradigm Capital Management Inc. NY now owns 535,700 shares of the medical device company’s stock worth $12,653,000 after acquiring an additional 148,600 shares during the last quarter. Finally, EVR Research LP lifted its holdings in Cutera by 45.4% in the third quarter. EVR Research LP now owns 400,000 shares of the medical device company’s stock worth $18,240,000 after acquiring an additional 124,983 shares during the last quarter.

About Cutera

(Get Rating)

Cutera, Inc engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo.